Embecta Corp. (EMBC) Financials
EMBC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 1.2 billion | 2.0 billion |
| 2023-12-31 | 1.2 billion | 2.0 billion |
| 2023-09-30 | 1.2 billion | 2.0 billion |
| 2023-06-30 | 1.3 billion | 2.1 billion |
EMBC Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | 20.9 million | 6.5 million |
| 2023-12-31 | -15.8 million | 7.3 million |
| 2023-09-30 | 20.4 million | 4.9 million |
| 2023-06-30 | -16.1 million | 5.3 million |
EMBC Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 28.9 million |
| 2023-12-31 | 20.1 million |
| 2023-09-30 | 6.0 million |
| 2023-06-30 | 15.2 million |
EMBC Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 306.5 million | - | 34.5 million |
| 2023-12-31 | 298.7 million | - | 34.8 million |
| 2023-09-30 | 326.5 million | - | 35.1 million |
| 2023-06-30 | 317.4 million | 1.6 billion | 35.4 million |
EMBC Shares Outstanding
EMBC Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 3.4 million | 18.4 million | 92.3 million | - |
| 2023-12-31 | 2.7 million | 20.2 million | 90.3 million | - |
| 2023-09-30 | 9.2 million | 23.6 million | 95.7 million | - |
| 2023-06-30 | 6.8 million | 22.6 million | 4.6 million | 83.0 million |
EMBC Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 287.2 million | 103.0 million |
| 2023-12-31 | 277.3 million | 91.4 million |
| 2023-09-30 | 281.9 million | 100.1 million |
| 2023-06-30 | 286.1 million | 96.6 million |
EMBC
Price: $12.43
Dividend Yield: 4.11%
Forward Dividend Yield: 4.71%
Payout Ratio: 62.50%
Dividend Per Share: 0.60 USD
Earnings Per Share: 1.22 USD
P/E Ratio: 15.59
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 652200
Market Capitalization: 842.0 million
Average Dividend Frequency: 4
Years Paying Dividends: 3